Shandong Boyuan Pharmaceutical&Chemical
301617
FORSTAR
835640
Cre8 Direct(Ningbo)Co.,Ltd.
300703
Minami Acoustics
301383
ASR Microelectronics
688220
CN Stock MarketDetailed Quotes
688036 Shenzhen Transsion Holdings Co., Ltd.
- 95.06
- +1.05+1.12%
Market Closed Dec 11 15:00 CST
108.40BMarket Cap19.51P/E (TTM)
96.77High92.68Low67.72KlotVolume93.80Open94.01Pre Close640.87MTurnover0.59%Turnover Ratio19.58P/E (Static)1.14BShares128.0152wk High5.84P/B108.40BFloat Cap69.5052wk Low112.81Limit Up1.14BShs Float178.19Historical High75.21Limit Down4.35%Amplitude17.23Historical Low5.79Dividend TTM94.64Avg Price29.77KlotAsk6.09%Div YieldTTM100Lot Size34.07KlotBid
Shenzhen Transsion Holdings Co., Ltd. Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 19.13%51.25B | 38.07%34.56B | 88.10%17.44B | 33.69%62.29B | 19.40%43.02B | 8.31%25.03B | -16.12%9.27B | -5.70%46.6B | 0.72%36.03B | 1.12%23.11B |
| Operating revenue | 19.13%51.25B | 38.07%34.56B | 88.10%17.44B | 33.69%62.29B | 19.40%43.02B | 8.31%25.03B | -16.12%9.27B | -5.70%46.6B | 0.72%36.03B | 1.12%23.11B |
| Total operating cost | 23.05%47.3B | 39.17%31.56B | 78.38%15.84B | 27.89%55.79B | 15.66%38.44B | 7.74%22.68B | -12.15%8.88B | -3.37%43.62B | 2.63%33.24B | 1.32%21.05B |
| Operating cost | 22.77%40.19B | 41.71%27.12B | 91.07%13.58B | 28.38%47.06B | 15.24%32.73B | 6.42%19.14B | -18.18%7.11B | -5.73%36.66B | 1.61%28.4B | 1.47%17.98B |
| Operating tax surcharges | -10.16%166.35M | -24.40%102.56M | 21.68%57.87M | 102.51%248.87M | 167.62%185.17M | 196.14%135.66M | 70.45%47.56M | 26.97%122.9M | -8.47%69.19M | -9.82%45.81M |
| Operating expense | 33.74%3.73B | 42.61%2.41B | 52.03%1.28B | 35.07%4.89B | 11.85%2.79B | 7.60%1.69B | 16.25%841.21M | 11.61%3.62B | 6.12%2.49B | -8.03%1.57B |
| Administration expense | 23.46%1.34B | 29.90%876.74M | 41.32%437.55M | 18.82%1.51B | 10.58%1.08B | 6.36%674.95M | 28.97%309.61M | -2.01%1.27B | 5.77%981.01M | 5.10%634.59M |
| Financial expense | 246.91%57.55M | -303.78%-131.05M | -376.55%-106.77M | -37.85%-175.97M | 81.53%-39.18M | 56.54%-32.45M | 22.27%38.61M | -215.71%-127.66M | -584.44%-212.15M | -247.44%-74.68M |
| -Interest expense (Financial expense) | 0.30%56.11M | 12.22%39.65M | 11.24%18.14M | 18.58%79.27M | 40.68%55.94M | 76.61%35.33M | 101.01%16.31M | 81.33%66.85M | 85.26%39.76M | 31.59%20.01M |
| -Interest Income (Financial expense) | -54.95%-262.32M | -140.20%-210.38M | -348.92%-169.46M | -92.22%-303.98M | -47.05%-169.29M | -11.65%-87.59M | -6.73%-37.75M | 5.61%-158.14M | 9.84%-115.13M | 7.21%-78.45M |
| Research and development | 7.87%1.82B | 10.32%1.18B | 10.35%588.78M | 8.56%2.26B | 12.64%1.69B | 20.58%1.07B | 34.97%533.55M | 37.54%2.08B | 44.80%1.5B | 39.09%889.61M |
| Credit Impairment Loss | 165.60%32.57M | -34.13%10.75M | 54.57%25.86M | -59.21%-79.66M | 0.38%-49.64M | 154.34%16.32M | 326.70%16.73M | -58.07%-50.03M | -43.62%-49.83M | -209.99%-30.03M |
| Asset Impairment Loss | -0.13%-234.7M | -15.58%-238.3M | -195.22%-81.55M | -16.70%-227.57M | -5.02%-234.39M | 15.04%-206.17M | 47.60%-27.63M | 5.62%-195M | -4.81%-223.18M | -21.96%-242.68M |
| Other net revenue | ||||||||||
| Fair value change income | 1.91%-74.24M | 19.71%-75.76M | 202.49%70.85M | 3.59%-68.16M | -20.98%-75.69M | -2,447.86%-94.36M | -596.33%-69.13M | -113.15%-70.7M | -131.82%-62.56M | -105.07%-3.7M |
| Invest income | 93.52%500.23M | 10.77%329.1M | -66.48%71.77M | 330.42%194.83M | 478.60%258.5M | 1,143.21%297.11M | 600.55%214.14M | 28.72%-84.55M | 63.12%-68.28M | 74.49%-28.48M |
| -Including: Investment income associates | 131.20%31.09M | 149.79%30.24M | 172.94%34.7M | 45.17%-95.52M | 36.47%-99.64M | 41.44%-60.75M | 19.43%-47.58M | 38.26%-174.23M | 31.88%-156.84M | 11.99%-103.73M |
| Asset deal income | 59.01%-1.35M | -801.02%-924.92K | -476.95%-1.02M | -294.34%-735.74K | -2,639.67%-3.29M | -77.24%131.94K | -52.24%271.92K | -104.77%-186.57K | -83.10%129.45K | 485.14%579.73K |
| Other revenue | 126.46%605.95M | 135.86%427.67M | 169.18%289.28M | -7.64%424.87M | -19.60%267.57M | -24.76%181.32M | -10.35%107.46M | 22.16%460M | 29.16%332.8M | 26.64%241M |
| Operating profit | 0.75%4.78B | 35.55%3.45B | 210.95%1.98B | 122.50%6.75B | 74.05%4.74B | 27.50%2.55B | -33.42%637.74M | -37.18%3.03B | -20.08%2.73B | -1.19%2B |
| Add:Non operating Income | 24.72%4.91M | 11.98%2.3M | 40.72%936.17K | 59.26%5.92M | 45.56%3.94M | 97.97%2.05M | -71.37%665.27K | -60.97%3.72M | -63.33%2.71M | -81.95%1.04M |
| Less:Non operating expense | -31.77%5.23M | -33.29%4.15M | -4.72%668.48K | -10.09%38.11M | 51.70%7.67M | 111.74%6.23M | -61.56%701.61K | -27.36%42.38M | 72.61%5.05M | 4.35%2.94M |
| Total profit | 0.83%4.78B | 35.70%3.45B | 211.01%1.98B | 124.30%6.71B | 74.06%4.74B | 27.41%2.54B | -33.46%637.7M | -37.35%2.99B | -20.25%2.72B | -1.43%2B |
| Less:Income tax cost | 1.48%839.83M | 33.68%587.71M | 206.30%348.21M | 114.04%1.13B | 76.71%827.58M | 28.47%439.62M | -30.72%113.68M | -39.20%526.68M | -13.61%468.33M | 14.82%342.21M |
| Net profit | 0.69%3.94B | 36.12%2.86B | 212.03%1.64B | 126.49%5.59B | 73.51%3.91B | 27.20%2.1B | -34.02%524.02M | -36.94%2.47B | -21.50%2.26B | -4.23%1.65B |
| Net profit from continuing operation | 0.69%3.94B | 36.12%2.86B | 212.03%1.64B | 126.49%5.59B | 73.51%3.91B | 27.20%2.1B | -34.02%524.02M | -36.94%2.47B | -21.50%2.26B | -4.23%1.65B |
| Less:Minority Profit | 26.36%36.58M | 359.17%12.43M | 6,095.94%8.62M | 394.95%50.02M | 1,115.52%28.95M | 210.24%2.71M | 89.89%-143.8K | -825.38%-16.96M | 67.61%-2.85M | 119.68%872.62K |
| Net profit of parent company owners | 0.50%3.9B | 35.70%2.85B | 210.30%1.63B | 122.93%5.54B | 72.01%3.88B | 27.10%2.1B | -34.12%524.16M | -36.46%2.48B | -21.64%2.26B | -4.53%1.65B |
| Earning per share | ||||||||||
| Basic earning per share | -28.36%3.46 | -3.07%2.53 | 210.77%2.02 | 122.65%6.88 | 71.89%4.83 | 26.70%2.61 | -34.34%0.65 | -36.68%3.09 | -21.94%2.81 | -5.07%2.06 |
| Diluted earning per share | -28.45%3.42 | -3.09%2.51 | 207.69%2 | 121.43%6.82 | 70.11%4.78 | 25.73%2.59 | -34.34%0.65 | -36.63%3.08 | -21.73%2.81 | -4.63%2.06 |
| Other composite income | -108.82%-2.74M | -145.79%-12.55M | 113.94%12.97M | -105.98%-7.53M | -75.56%31.05M | -69.66%27.41M | -536.43%-93.08M | 386.36%125.94M | 274.09%127M | 293.17%90.36M |
| Other composite income of parent company owners | -84.44%3.88M | -136.33%-9.86M | 110.74%10.65M | -95.29%6.05M | -80.78%24.93M | -69.27%27.13M | -627.41%-99.2M | 351.34%128.36M | 277.95%129.69M | 298.55%88.29M |
| Other composite income of minority owners | -208.25%-6.62M | -1,058.92%-2.69M | -62.05%2.32M | -461.04%-13.58M | 327.79%6.11M | -86.41%280.89K | 142.65%6.11M | -134.13%-2.42M | -3,524.09%-2.68M | 189.51%2.07M |
| Total composite income | -0.17%3.94B | 33.78%2.85B | 282.44%1.65B | 115.20%5.58B | 65.57%3.94B | 22.18%2.13B | -47.16%430.94M | -32.96%2.59B | -14.92%2.38B | 3.81%1.74B |
| Total composite income of parent company owners | -0.05%3.91B | 33.51%2.84B | 285.24%1.64B | 112.21%5.54B | 63.71%3.91B | 22.21%2.13B | -47.82%424.97M | -32.30%2.61B | -14.99%2.39B | 3.22%1.74B |
| Total composite income of minority owners | -14.54%29.97M | 225.86%9.74M | 83.27%10.94M | 288.04%36.44M | 733.51%35.07M | 1.63%2.99M | 444.12%5.97M | -305.53%-19.38M | 37.63%-5.54M | 143.60%2.94M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
